{"id":11127,"date":"2024-10-23T10:00:34","date_gmt":"2024-10-23T03:00:34","guid":{"rendered":"https:\/\/chgcancercenter.com\/?p=11127"},"modified":"2024-10-25T18:22:46","modified_gmt":"2024-10-25T11:22:46","slug":"gene-mutations-non-smoking-women-precise-lung-cancer-treatment","status":"publish","type":"post","link":"https:\/\/chgcancercenter.com\/en\/gene-mutations-non-smoking-women-precise-lung-cancer-treatment\/","title":{"rendered":"Non-Smoking Women at Risk of Lung Cancer from Gene Mutations"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Non-Smoking Women at Risk of Lung Cancer from Gene Mutations<\/strong><\/span><\/h1>

Lung cancer remains one of the deadliest diseases worldwide, claiming countless lives each year. While smoking is the primary cause of lung cancer, a significant number of patients, especially women, who have never smoked are diagnosed with the disease. Remarkably, over half of non-smoking women with lung cancer are found to have gene mutations.<\/p>

Gene Mutations and Lung Cancer in Non-Smoking Women<\/b><\/span><\/h2>

Research shows that most non-smoking lung cancer patients are women, with more than 50% of them having mutations in key genes. These mutations often involve abnormal cell growth signaling pathways, such as mutations in the EGFR (Epidermal Growth Factor Receptor) and ALK (Anaplastic Lymphoma Kinase) genes.<\/p>

Genetic Testing: The Key to Treatment<\/b><\/span><\/h2>

Today, testing for gene mutations is a crucial step in lung cancer treatment planning. Some gene mutations respond effectively to targeted therapy, which works by attacking cancer cells with specific mutations, sparing normal cells and reducing the side effects seen with chemotherapy.<\/p>

Examples of targeted therapies include:<\/span><\/p>